Propensity matching was used to assess whether prescribed semaglutide was associated with NAION in patients with type 2 diabetes (T2D) or overweight/obesity, in each case accounting for covarying factors (sex, age, systemic hypertension, T2D, obstructive sleep apnoea, obesity, hyperlipidemia, and coronary artery disease) and contraindications for use of semaglutide
Asthma and obesity: does weight loss improve asthma control
Weeks 48 (Texture and Tone): Skin texture typically becomes smoother
(Coates et al
The combination of 300 mg pomegranate seed oil and 300 mg brown seaweed extract containing 2.4 mg fucoxanthin significantly resulted in the reduction of body weight and liver fat content in obese women who were treated for 16 days [25]
However, genetic predisposition is not deterministic of exact medication response